← Product Code [FLF](/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/FLF) · K090636 # TSO3 OZONE STERILIZER, MODEL 125L (K090636) _Tso3, Inc. · FLF · Dec 2, 2009 · General Hospital · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/FLF/K090636 ## Device Facts - **Applicant:** Tso3, Inc. - **Product Code:** [FLF](/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/FLF.md) - **Decision Date:** Dec 2, 2009 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 880.6860 - **Device Class:** Class 2 - **Review Panel:** General Hospital ## Indications for Use TSO3 125L Ozone Sterilizer is intended for use in the sterilization processing of reusable medical devices in health care facilities. TSO 125L Ozone Sterilizer is designed for sterilization of both metal and non-metal medical devices at low temperatures. TSO3 125L Ozone Sterilizer has the ability to sterilize successfully packaged rigid and flexible lumen medical devices, including single and multi channel flexible endoscopes such as fiberoptic and video endoscopes. ## Device Story TSO3 125L Ozone Sterilizer is a low-temperature sterilization system for previously cleaned, packaged reusable medical devices. Device uses ozone gas as the sterilant; requires USP grade oxygen, water, and electricity. Operates via a factory-programmed control system; no aeration required post-cycle. Items are cool to touch and ready for immediate use or storage. Used in healthcare facilities; operated by trained personnel. Sterilization process involves exposure to 85 mg/L ozone for 15 minutes at 30.8°C–36.1°C. Benefits include rapid turnaround of heat-sensitive instruments like flexible endoscopes without toxic gas aeration. ## Clinical Evidence Bench testing only. Validation performed using overkill approach, half-cycle, and simulated use conditions to demonstrate sterilization efficacy for flexible endoscopes. Testing achieved a sterility assurance level (SAL) of 10^-6. Load configuration included multi-channel and single-channel endoscopes (total 14 channels) plus 14 additional medical devices (49 lbs total). Material effects, functional compatibility, and biocompatibility were evaluated to confirm safety. ## Technological Characteristics 125-liter sterilization chamber; ozone gas sterilant; requires USP grade oxygen, water, and electricity. Compatible with non-woven wrapping, pouches, and anodized aluminum containers. Operates at 30.8°C–36.1°C. Factory-programmed control system. No exhaust ventilation required if room is adequately ventilated. By-products are oxygen and water vapor. ## Regulatory Identification An ethylene gas sterilizer is a nonportable device intended for use by a health care provider that uses ethylene oxide (ETO) to sterilize medical products. ## Predicate Devices - TSO3 Ozone Sterilizer, model 125L ([K020875](/device/K020875.md)) - TSO3 Ozone Sterilizer, model 125L ([K051595](/device/K051595.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ TSO ### RILIZATION OF FLEXIBLE ENDOSCOPES INTO HE TSO2 OZONE STERILIZER. MODEL 125L JC090636 ## 510(k) Summary DEC - 2 2009 ## Applicant's Name and Address TSO3 Inc. 2505 avenue Dalton Québec, Qc Canada G1P 3S5 ## Contact Person, Telephone, FAX Marc Chaunet, Director of Quality Assurance and Regulatory Affairs Tel : (418) 651-0003 FAX : (418) 653-5726 E-mail : mchaunet@tso3.com # U.S. Agent Charles O. Hancock Inc. Contact person: Charles O. Hancock, RAC Tel : (585) 223-1850 FAX : (585) 223-6855 E-mail : chancock@rochester.rr.com # Submission Date March 4, 2009 ## Trade Name TSO3 STERIZONE® 125L Sterilizer # Common Name TSO3 125L Ozone Sterilizer {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows a chemical structure diagram. The diagram depicts the letters "TSO" with a circle above the "O". The letters are in a simple, sans-serif font and are arranged horizontally. The diagram is simple and lacks any additional details. ### STERILIZATION OF FLEXIBLE EN E TSO3 OZONE STERILIZER. MODEL 125/ ## Classification Name Sterilizer, Chemical Class II (as per 21CFR, part 880.6860 equivalent device) # Legally Marketed Equivalent Device Name(s) TSO3 Ozone Sterilizer, model 125L (K020875) (K051595) # Description of Device TSO3 Ozone Sterilizer, model 125L is intended to sterilize medical devices that has been previously cleaned. The sterilization chamber has a capacity of 125 liters (4.3 cu. ft.). It requires USP grade oxygen, water and electricity. TSO3 Sterilizer could be installed as a free standing unit or recessed behind the wall. No exhaust gas ventilation duct is required as long as the room is adequately ventilated. By-products are oxygen and low humidity water vapor. Model 125L is equipped with a unique factory-programmed control system. Non-woven wrapping material or pouches and anodized aluminum containers are used as packaging for medical devices to be sterilized. OZO-TEST® self-contained Biological Indicators (B. stearothermophilus) are recommended for use in evaluating cycle performance. TSO3 Chemical Indicators are available for this process. No aeration is needed following the sterilization cycle. The sterilized items are cool to the touch and can be removed immediately and used, or stored for future use. ### Effectiveness Ozone Sterilizer validation testing for sterilization of flexible endoscopes was performed using the « overkill » approach to demonstrate the effectiveness of the process. {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows a chemical structure diagram. The diagram includes the letters "TS" on the left side. To the right of the letters, there is a chemical structure with circles and lines, representing atoms and bonds. The structure appears to be a simplified representation of a molecule, possibly an organic compound. ## STERILIZATION OF FLEXIBLE ENDOSCOPES INTO THE TSO3 OZONE STERILIZER, MODEL 125L The effectiveness of the ozone sterilization process in sterilization of flexible endoscopes is demonstrated by the full cycle validation testing in simulated use conditions, half-cycle validation testing and in-use testing. # Safety Safety of the TSO3 Ozone Sterilizer, model 125L was demonstrated into the original 510(k) submission (K020875). The content of the actual submittal does not compromise the safety of the device. The safety of the ozone sterilization process in sterilization of flexible endoscopes is demonstrated by the processed device/material qualification testing which includes material effects, functional compatibility and biocompatibility evaluation. {3}------------------------------------------------ Image /page/3/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized depiction of an eagle or bird-like figure with outstretched wings, symbolizing protection and care. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the emblem. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-O66-0609 Silver Spring, MD 20993-0002 TSO3 Incorporated C/O Mr. Charles O. Hancock Regulatory Affairs Consultant Charles O. Hancock Associates, Incorporated 33 Black Watch Trail Fairport. New York 14450 DEC - 2 2009 Re: K090636 Trade/Device Name: TSO3 Ozone Sterilizer, Model 125L Regulation Number: 21 CFR 880.6860 Regulation Name: Ethylene Oxide Gas Sterilizer Regulatory Class: II Product Code: FLF Dated: November 12, 2009 Received: November 12, 2009 Dear Mr. Hancock: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {4}------------------------------------------------ ### Page 2- Mr. Hancock Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/cdrh/mdr/ for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Antman Q. muster for Susan Runner, D.D.S., M.A. Acting Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health ### Enclosure {5}------------------------------------------------ # Indications for Use 510(k) Number (if known): K090636 Device Name: TSO3 Ozone Sterilizer, model 125L ### Indications for Use: TSO3 125L Ozone Sterilizer is intended for use in the sterilization processing of reusable medical devices in health care facilities. TSO 125L Ozone Sterilizer is designed for sterilization of both metal and non-metal medical devices at low temperatures. TSO3 125L Ozone Sterilizer has the ability to sterilize successfully packaged rigid and flexible lumen medical devices, including single and multi channel flexible endoscopes such as fiberoptic and video endoscopes. Notes: - · Testing on flexible endoscopes was conducted employing half cycle to demonstrate achievement of a sterility assurance level (SAL) of 10°. - · During the sterilization cycle, items are exposed to ozone at a concentration of 85 milligrams per liter for 15 minutes at a temperature of 30.8℃ to 36.1℃ (87.4 F to 97 F). - · Sterilization efficacy was demonstrated for a load comprising packaged multi channel (2) and single channel (1) flexible endoscopes having a total of 14 channels in the presence of other packaged medical devices. The load configuration used for qualification testing contained 2 multi channel and one single channel flexible endoscope, plus 14 medical devices packaged in TSO3 Sterliization Pouches and a Process Challenge Device. Total weight of the load was 49 lbs. · For the purpose of this submission: - · Single channel flexible endoscopes refer to medical devices having only one channel. - · Multi channel flexible endoscopes refer to medical devices that may have two or more channels such as: Working channel (biopsy); Water jet; Air feeding; Water feeding; Suction; - · Endoscopes evaluated include: Colonoscope, Gastroscope, Broncho videoscope, Choledofiberscope and Ureteroscope. AND/OR Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use X (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Page 1 of Division of Anesthesiology, General Hospital Infection Control, Dental Devices (Division Sign-Off) 510(k) Number: 19063600 --- **Source:** [https://fda.innolitics.com/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/FLF/K090636](https://fda.innolitics.com/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/FLF/K090636) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com